<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">25083781</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2014</Year>
        <Month>08</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1542-233X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>40</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2014</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Eye &amp; contact lens</Title>
          <ISOAbbreviation>Eye Contact Lens</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antimicrobial contact lenses and lens cases: a review.</ArticleTitle>
        <Pagination>
          <StartPage>312</StartPage>
          <EndPage>324</EndPage>
          <MedlinePgn>312-24</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/ICL.0000000000000056</ELocationID>
        <Abstract>
          <AbstractText>Antimicrobial agents are being examined with the aim of developing antimicrobial contact lenses and new forms of antimicrobial lens cases. It is hoped that these developments will result in reduced contact lens-related microbial adverse events. In this review, we assess aspects of various antimicrobial strategies, such as cationic metals and peptides, selenium, quorum sensing inhibitors, and various biocidal and non-cidal agents. We highlight the historical challenges, the current scenario of this field, and recommendations for future antimicrobial strategies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dutta</LastName>
            <ForeName>Debarun</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>School of Optometry and Vision Science (D.D., M.D.P.W.), The University of New South Wales, Sydney, New South Wales, Australia; and Brien Holden Vision Institute (D.D.), Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Willcox</LastName>
            <ForeName>Mark D P</ForeName>
            <Initials>MD</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Eye Contact Lens</MedlineTA>
        <NlmUniqueID>101160941</NlmUniqueID>
        <ISSNLinking>1542-2321</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003261" MajorTopicYN="Y">Contact Lenses</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004866" MajorTopicYN="N">Equipment Contamination</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015818" MajorTopicYN="N">Eye Infections, Bacterial</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2014</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2014</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25083781</ArticleId>
        <ArticleId IdType="doi">10.1097/ICL.0000000000000056</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
